Posttranscriptional regulation by RNA-binding proteins during epithelial-to-mesenchymal transition

Luís Antón Aparicio(Universidade da Coruña), Angélica Figueroa(Universidade da Coruña), Vanessa Abella(Complexo Hospitalario Universitario A Coruña), Manuel Valladares(American Society of Clinical Oncology)

Cellular and Molecular Life Sciences

May 28, 2013

10.1007/s00018-013-1379-0

Cited by 54

Related Papers

Cancer drug resistance induced by EMT: novel therapeutic strategies

|Archives of Toxicology|2021|220

First-Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single-Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO TTD Study

|The Oncologist|2012|213

Potential Role of Sugar Transporters in Cancer and Their Relationship with Anticancer Therapy

|International Journal of Endocrinology|2010|175

Irinotecan in Combination With Fluorouracil in a 48-Hour Continuous Infusion As First-Line Chemotherapy for Elderly Patients With Metastatic Colorectal Cancer: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study

|Journal of Clinical Oncology|2005|98

Circulating Tumor Cell Count Is a Prognostic Factor in Metastatic Colorectal Cancer Patients Receiving First-Line Chemotherapy Plus Bevacizumab: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study

|The Oncologist|2012|88